TETRALOGIC PHARMACEUTICALS CORP Debt Conversion, Converted Instrument, Amount
TETRALOGIC PHARMACEUTICALS CORP reported Debt Conversion, Converted Instrument, Amount of $2.08 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2016-03-16
- TETRALOGIC PHARMACEUTICALS CORP debt conversion, converted instrument, amount for fiscal 2015 was $2.08M.
- TETRALOGIC PHARMACEUTICALS CORP debt conversion, converted instrument, amount for fiscal 2013 was $20.13M.
| Period end | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|
| 2015-12-31 | $2.08M 10-K · filed 2016-03-16 |
| 2013-12-31 | $20.13M 10-K · filed 2015-02-26 |